Introduction And Patient Selection

  • Epilepsy surgery is no longer a salvage therapy but a time-sensitive, early disease-modifying intervention offering a definitive cure for pediatric drug-resistant epilepsy (DRE).
  • Uncontrolled seizures in a developing brain trigger epileptic encephalopathy, halting synapse formation and inducing severe, irreversible cognitive and behavioral regression.
  • Drug-Resistant Epilepsy is defined as the failure of adequate trials of two tolerated and appropriately chosen anti-seizure medication (ASM) schedules to achieve sustained seizure freedom.

Guidelines And Referral Mandates (2025–2026)

  • International guidelines mandate that any child meeting DRE criteria must be referred to a Level 4 Comprehensive Epilepsy Care Center within six months of diagnosis.
  • Subjecting a child to sequential trials beyond two ASMs is strongly discouraged, as the probability of a third ASM achieving seizure freedom is less than 4%.
  • Catastrophic early-onset epilepsies (e.g., infantile spasms, Sturge-Weber syndrome) require emergency surgical evaluation in early infancy.

Pre-Surgical Evaluation Modalities

The objective is to precisely map the Epileptogenic Zone (EZ) while rigorously preserving eloquent cortex.

PhaseEvaluation ModalityClinical Utility And Mechanism
Phase I (Non-Invasive)Ultra-High Field 7T MRIProvides exquisite spatial resolution to detect subtle, previously "MRI-negative" lesions like Focal Cortical Dysplasia (FCD).
Phase IMorphometric Analysis Program (MAP) & AIUses AI-driven post-processing software to compare the child's gray-white matter junction against normative databases, flagging visually imperceptible focal dysplasias.
Phase IPET/MRI Fusion & SISCOMCombines FDG-PET (interictal hypometabolism) and Subtraction Ictal SPECT Coregistered to MRI (ictal hyperperfusion) to create accurate 3D seizure network models.
Phase IMagnetoencephalography (MEG)Detects magnetic fields undistorted by the skull; gold standard for mapping the irritative zone and localizing the primary somatosensory cortex.
Phase II (Invasive)Stereoelectroencephalography (SEEG)Utilizes Robotic Stereotactic Assistance (ROSA) to insert depth electrodes into deep 3D networks, bypassing the severe morbidities associated with traditional subdural grids.

Surgical And Neuromodulatory Modalities

Surgical ClassSpecific ProcedureMechanism And Indications
ResectiveAnterior Temporal LobectomyTargeted excision forming the most frequent procedure for medically refractory mesial temporal lobe epilepsy.
DisconnectiveEndoscopic Functional HemispherotomyEndoscopic disconnection of white matter pathways; preferred over anatomical hemispherectomy to prevent massive blood loss and hemosiderosis in catastrophic hemispheric syndromes.
DisconnectiveCorpus CallosotomyPalliative division of the corpus callosum to eliminate debilitating generalized atonic "drop attacks" in Lennox-Gastaut syndrome.
Minimally InvasiveMRI-Guided Laser Interstitial Thermal Therapy (MR-gLiTT)Stereotactic insertion of a 1.5mm laser fiber into deep lesions (e.g., hypothalamic hamartomas); utilizes real-time MR thermometry to coagulate tissue safely.
Minimally InvasiveRadiofrequency Thermocoagulation (RF-TC)Delivers a radiofrequency current directly through pre-existing SEEG electrodes to cure small focal dysplasias without open resection.

Precision Genetics And Outcomes

  • Somatic Genetics: FCDs and Hemimegalencephaly are frequently driven by post-zygotic, somatic mutations isolated to brain tissue (e.g., MTOR, DEPDC5, BRAF).
  • Targeted Pharmacotherapy: If incomplete resection occurs to spare eloquent cortex, post-operative precision therapy with mTOR inhibitors (like Everolimus) can suppress the remaining epileptogenic network.
  • Neuromodulation: For unresectable, multifocal, or eloquent-cortex-involved epilepsy, Responsive Neurostimulation (RNS) detects seizure onset and delivers automated micro-shocks to abort ictal activity.
  • Prognosis And Plasticity: Surgical outcomes are categorized using the Engel Outcome Scale, with focal resections achieving Class I seizure freedom in 60% to 80% of children.
  • Plasticity Window: Operating early capitalizes on the developing brain's neuroplasticity, driving massive improvements in IQ and preventing permanent deficits (e.g., aphasia) via hemispheric functional transfer.